Breaking the deadlock in antigen discovery for Leishmania vaccines
- 2 March 2026
- journal article
- review article
- Published by Elsevier in Trends in Parasitology
- Vol. 42 (3) , 183-191
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Identifying WHO global priority endemic pathogens for vaccine research and development (R&D) using multi-criteria decision analysis (MCDA): an objective of the Immunization Agenda 2030EBioMedicine, 2024
- MAPK/ERK activation in macrophages promotes Leishmania internalization and pathogenesisMicrobes and Infection, 2024
- Incongruity between T cell receptor recognition of breast cancer hotspot mutations ESR1 Y537S and D538G following exogenous peptide loading versus endogenous antigen processingCytotherapy, 2024
- HLAEquity: Examining biases in pan-allele peptide-HLA binding predictorsiScience, 2023
- Spatial maps of T cell receptors and transcriptomes reveal distinct immune niches and interactions in the adaptive immune responseImmunity, 2022
- Standing on the shoulders of miceImmunity, 2022
- Recent advances in T-cell receptor repertoire analysis: Bridging the gap with multimodal single-cell RNA sequencingImmunoInformatics, 2022
- On the feasibility of mining CD8+ T cell receptor patterns underlying immunogenic peptide recognitionImmunogenetics, 2017
- Memory T cells in cutaneous leishmaniasisCellular Immunology, 2016
- Confronting Complexity: Real-World Immunodominance in Antiviral CD8+ T Cell ResponsesImmunity, 2006